High-altitude pulmonary edema: Difference between revisions
mNo edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = High-altitude pulmonary edema | |||
| image = [[File:Chest_XR_of_HAPE.png|250px]] | |||
| caption = Chest X-ray showing high-altitude pulmonary edema | |||
| field = [[Pulmonology]] | |||
| symptoms = [[Shortness of breath]], [[cough]], [[chest tightness]], [[fatigue]], [[cyanosis]] | |||
| complications = [[Respiratory failure]], [[coma]], [[death]] | |||
| onset = Typically 2 to 4 days after ascent to high altitude | |||
| duration = Variable, can resolve with descent or treatment | |||
| causes = [[Hypoxia]] due to high altitude | |||
| risks = Rapid ascent, previous history of HAPE, physical exertion | |||
| diagnosis = [[Clinical diagnosis]], [[chest X-ray]], [[oxygen saturation]] | |||
| differential = [[Pneumonia]], [[pulmonary embolism]], [[acute mountain sickness]] | |||
| prevention = Gradual ascent, [[acetazolamide]], [[nifedipine]] | |||
| treatment = Descent to lower altitude, [[supplemental oxygen]], [[hyperbaric therapy]] | |||
| prognosis = Good with prompt treatment, can be fatal if untreated | |||
| frequency = Occurs in 0.2% to 15% of individuals ascending to altitudes above 2,500 meters | |||
}} | |||
= High Altitude Pulmonary Edema (HAPE) = | = High Altitude Pulmonary Edema (HAPE) = | ||
== Introduction == | == Introduction == | ||
'''High Altitude Pulmonary Edema (HAPE)''' is a severe form of [[Altitude sickness|altitude sickness]], characterized by the accumulation of fluid in the lungs. HAPE occurs due to prolonged exposure to high altitudes where oxygen levels are significantly lower. | '''High Altitude Pulmonary Edema (HAPE)''' is a severe form of [[Altitude sickness|altitude sickness]], characterized by the accumulation of fluid in the lungs. HAPE occurs due to prolonged exposure to high altitudes where oxygen levels are significantly lower. | ||
[[File:Lungenoedem etwas asymmetrisch und Rekompensation nach 3 Tagen 74W - CR pa - 001.jpg|left|thumb|500px|Representation of High Altitude Pulmonary Edema]] | |||
[[File:Lungenoedem etwas asymmetrisch und Rekompensation nach 3 Tagen 74W - CR pa - 001.jpg|thumb|500px|Representation of High Altitude Pulmonary Edema]] | |||
== Causes and Risk Factors == | == Causes and Risk Factors == | ||
HAPE is primarily caused by rapid ascent to high altitudes, typically above 2,500 meters (8,200 feet). Risk factors include: | HAPE is primarily caused by rapid ascent to high altitudes, typically above 2,500 meters (8,200 feet). Risk factors include: | ||
| Line 11: | Line 27: | ||
* Physical exertion without adequate acclimatization. | * Physical exertion without adequate acclimatization. | ||
* Individual susceptibility, with some people being more prone to altitude sickness. | * Individual susceptibility, with some people being more prone to altitude sickness. | ||
== Pathophysiology == | == Pathophysiology == | ||
At high altitudes, decreased oxygen pressure leads to abnormal blood flow in the lungs, causing fluid to leak from blood vessels into lung tissue. This results in impaired gas exchange and respiratory distress. | At high altitudes, decreased oxygen pressure leads to abnormal blood flow in the lungs, causing fluid to leak from blood vessels into lung tissue. This results in impaired gas exchange and respiratory distress. | ||
== Symptoms and Diagnosis == | == Symptoms and Diagnosis == | ||
Symptoms of HAPE typically manifest within 2 to 4 days after ascent and may include: | Symptoms of HAPE typically manifest within 2 to 4 days after ascent and may include: | ||
| Line 22: | Line 36: | ||
* Cyanosis (bluish discoloration of the skin due to low oxygen levels). | * Cyanosis (bluish discoloration of the skin due to low oxygen levels). | ||
Diagnosis is often based on the presence of these symptoms, a physical examination, and sometimes a chest X-ray or pulse oximetry. | Diagnosis is often based on the presence of these symptoms, a physical examination, and sometimes a chest X-ray or pulse oximetry. | ||
== Treatment and Management == | == Treatment and Management == | ||
Immediate treatment is crucial and includes: | Immediate treatment is crucial and includes: | ||
| Line 28: | Line 41: | ||
* Administration of supplemental oxygen. | * Administration of supplemental oxygen. | ||
* Use of medications like nifedipine or acetazolamide, under medical supervision. | * Use of medications like nifedipine or acetazolamide, under medical supervision. | ||
== Prevention == | == Prevention == | ||
Prevention of HAPE involves: | Prevention of HAPE involves: | ||
| Line 34: | Line 46: | ||
* Avoiding overexertion during the first few days at high altitude. | * Avoiding overexertion during the first few days at high altitude. | ||
* Recognizing early symptoms of altitude sickness and responding appropriately. | * Recognizing early symptoms of altitude sickness and responding appropriately. | ||
== External Links == | == External Links == | ||
* [https://www.altitudemedicine.org/high-altitude-pulmonary-edema-hape/ Institute for Altitude Medicine: High Altitude Pulmonary Edema (HAPE)] | * [https://www.altitudemedicine.org/high-altitude-pulmonary-edema-hape/ Institute for Altitude Medicine: High Altitude Pulmonary Edema (HAPE)] | ||
* [https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/altitude-illness Centers for Disease Control and Prevention: Altitude Illness] | * [https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/altitude-illness Centers for Disease Control and Prevention: Altitude Illness] | ||
== References == | == References == | ||
<references/> | <references/> | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1114067/ National Center for Biotechnology Information: High Altitude Pulmonary Edema] | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1114067/ National Center for Biotechnology Information: High Altitude Pulmonary Edema] | ||
* [https://www.uptodate.com/contents/high-altitude-pulmonary-edema-hape UpToDate: High Altitude Pulmonary Edema (HAPE)] | * [https://www.uptodate.com/contents/high-altitude-pulmonary-edema-hape UpToDate: High Altitude Pulmonary Edema (HAPE)] | ||
[[Category:Respiratory Diseases]] | [[Category:Respiratory Diseases]] | ||
[[Category:Altitude Medicine]] | [[Category:Altitude Medicine]] | ||
[[Category:Emergency Medical Conditions]] | [[Category:Emergency Medical Conditions]] | ||
{{stub}} | {{stub}} | ||
Latest revision as of 04:48, 7 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| High-altitude pulmonary edema | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Shortness of breath, cough, chest tightness, fatigue, cyanosis |
| Complications | Respiratory failure, coma, death |
| Onset | Typically 2 to 4 days after ascent to high altitude |
| Duration | Variable, can resolve with descent or treatment |
| Types | N/A |
| Causes | Hypoxia due to high altitude |
| Risks | Rapid ascent, previous history of HAPE, physical exertion |
| Diagnosis | Clinical diagnosis, chest X-ray, oxygen saturation |
| Differential diagnosis | Pneumonia, pulmonary embolism, acute mountain sickness |
| Prevention | Gradual ascent, acetazolamide, nifedipine |
| Treatment | Descent to lower altitude, supplemental oxygen, hyperbaric therapy |
| Medication | N/A |
| Prognosis | Good with prompt treatment, can be fatal if untreated |
| Frequency | Occurs in 0.2% to 15% of individuals ascending to altitudes above 2,500 meters |
| Deaths | N/A |
High Altitude Pulmonary Edema (HAPE)[edit]
Introduction[edit]
High Altitude Pulmonary Edema (HAPE) is a severe form of altitude sickness, characterized by the accumulation of fluid in the lungs. HAPE occurs due to prolonged exposure to high altitudes where oxygen levels are significantly lower.

Causes and Risk Factors[edit]
HAPE is primarily caused by rapid ascent to high altitudes, typically above 2,500 meters (8,200 feet). Risk factors include:
- A faster rate of ascent than recommended.
- Physical exertion without adequate acclimatization.
- Individual susceptibility, with some people being more prone to altitude sickness.
Pathophysiology[edit]
At high altitudes, decreased oxygen pressure leads to abnormal blood flow in the lungs, causing fluid to leak from blood vessels into lung tissue. This results in impaired gas exchange and respiratory distress.
Symptoms and Diagnosis[edit]
Symptoms of HAPE typically manifest within 2 to 4 days after ascent and may include:
- Shortness of breath, even at rest.
- Persistent dry cough, which may progress to pink, frothy sputum.
- Weakness and reduced exercise capacity.
- Cyanosis (bluish discoloration of the skin due to low oxygen levels).
Diagnosis is often based on the presence of these symptoms, a physical examination, and sometimes a chest X-ray or pulse oximetry.
Treatment and Management[edit]
Immediate treatment is crucial and includes:
- Descending to a lower altitude as quickly and safely as possible.
- Administration of supplemental oxygen.
- Use of medications like nifedipine or acetazolamide, under medical supervision.
Prevention[edit]
Prevention of HAPE involves:
- Gradual ascent to allow time for acclimatization.
- Avoiding overexertion during the first few days at high altitude.
- Recognizing early symptoms of altitude sickness and responding appropriately.
External Links[edit]
- Institute for Altitude Medicine: High Altitude Pulmonary Edema (HAPE)
- Centers for Disease Control and Prevention: Altitude Illness
References[edit]
<references/>


